Literature DB >> 25023065

What causes some patients with drug-induced QT interval prolongation to develop torsades de pointes but not others? The elusive missing link.

James E Tisdale1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25023065     DOI： 10.1007/s40266-014-0199-8

Source DB:  PubMed          Journal:  Drugs Aging        ISSN： 1170-229X            Impact factor:   3.923


× No keyword cloud information.
  18 in total

Review 1.  Drug-induced prolongation of the QT interval.

Authors:  Dan M Roden
Journal:  N Engl J Med       Date:  2004-03-04       Impact factor: 91.245

2.  Inaccurate electrocardiographic interpretation of long QT: the majority of physicians cannot recognize a long QT when they see one.

Authors:  Sami Viskin; Uri Rosovski; Andrew J Sands; Edmond Chen; Peter M Kistler; Jonathan M Kalman; Laura Rodriguez Chavez; Pedro Iturralde Torres; Fernando E S Cruz F; Osmar A Centurión; Akira Fujiki; Philippe Maury; Xiaomin Chen; Andrew D Krahn; Franz Roithinger; Li Zhang; G Michael Vincent; David Zeltser
Journal:  Heart Rhythm       Date:  2005-06       Impact factor: 6.343

3.  Accuracy of uncorrected versus corrected QT interval for prediction of torsade de pointes associated with intravenous haloperidol.

Authors:  James E Tisdale; Richard Kovacs; Deming Mi; George P McCabe; Beth L Cariera; Nagaraja Sharma; Howard Rosman
Journal:  Pharmacotherapy       Date:  2007-02       Impact factor: 4.705

4.  Cumulative experience of azimilide-associated torsades de pointes ventricular tachycardia in the 19 clinical studies comprising the azimilide database.

Authors:  Craig M Pratt; Hussein R Al-Khalidi; Jose M Brum; Michael J Holroyde; Peter J Schwartz; Stephen R Marcello; Martin Borggrefe; Paul Dorian; A John Camm
Journal:  J Am Coll Cardiol       Date:  2006-07-12       Impact factor: 24.094

5.  Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation.

Authors:  Barbara J Drew; Michael J Ackerman; Marjorie Funk; W Brian Gibler; Paul Kligfield; Venu Menon; George J Philippides; Dan M Roden; Wojciech Zareba
Journal:  Circulation       Date:  2010-02-08       Impact factor: 29.690

6.  Determinants of torsades de pointes in older patients with drug-associated long QT syndrome: a case-control study.

Authors:  Sylvain Goutelle; Elodie Sidolle; Michel Ducher; Jacques Caron; Quadiri Timour; Patrice Nony; Aurore Gouraud
Journal:  Drugs Aging       Date:  2014-08       Impact factor: 3.923

7.  Prescription of QT-prolonging drugs in a cohort of about 5 million outpatients.

Authors:  Lesley H Curtis; Truls Østbye; Veronica Sendersky; Steve Hutchison; Nancy M Allen LaPointe; Sana M Al-Khatib; Sally Usdin Yasuda; Peter E Dans; Alan Wright; Robert M Califf; Raymond L Woosley; Kevin A Schulman
Journal:  Am J Med       Date:  2003-02-01       Impact factor: 4.965

8.  Risk factors for prolonged QTc among US adults: Third National Health and Nutrition Examination Survey.

Authors:  Stephen R Benoit; Aaron B Mendelsohn; Parivash Nourjah; Judy A Staffa; David J Graham
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2005-08

9.  Mechanism of the cardiotoxic actions of terfenadine.

Authors:  R L Woosley; Y Chen; J P Freiman; R A Gillis
Journal:  JAMA       Date:  1993 Mar 24-31       Impact factor: 56.272

10.  The association of serum testosterone levels and ventricular repolarization.

Authors:  Charlotte van Noord; Marcus Dörr; Miriam C J M Sturkenboom; Sabine M J M Straus; Thorsten Reffelmann; Stephan B Felix; Albert Hofman; Jan A Kors; Robin Haring; Frank H de Jong; Matthias Nauck; André G Uitterlinden; Henri Wallaschofski; Jacqueline C M Witteman; Henry Völzke; Bruno H Ch Stricker
Journal:  Eur J Epidemiol       Date:  2009-12-03       Impact factor: 8.082
View more
  2 in total

1.  High prevalence of risk factors in elderly patients using drugs associated with acquired torsades de pointes chronically in Colombia.

Authors:  Paula Andrea Moreno-Gutiérrez; Andrés Gaviria-Mendoza; Mauricio Montoya Cañón; Jorge Enrique Machado-Alba
Journal:  Br J Clin Pharmacol       Date:  2016-05-21       Impact factor: 4.335

2.  Co-Prescription of QT-Interval Prolonging Drugs: An Analysis in a Large Cohort of Geriatric Patients.

Authors:  Simone Schächtele; Thomas Tümena; Karl-Günter Gaßmann; Martin F Fromm; Renke Maas
Journal:  PLoS One       Date:  2016-05-18       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.